Skip to content
Screener

Schrodinger SDGR Total Revenue

Total Revenue at other companies

Cadence Design Systems logo
Cadence Design SystemsCDNS
$1.58B+24.2%
Simulations Plus logo
Simulations PlusSLP
$21.89M+7.5%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$7.67M-60.1%
Absci Corporation logo
Absci CorporationABSI
$215K-81.8%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$4.05M-76.3%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$350K-48.3%

Segments

By product

See full
Hosted software$15.15M+36.1%
On-premise software$9.3M-40.9%
Software maintenance$4.88M-28.0%
Professional services$3.22M+35.1%

By geography

See full
APAC$14.38M+6.0%
EMEA$6.7M-3.9%
Rest of World$285K+62.9%

By segment

See full
Software$35.47M-12.5%
Drug Discovery$23.42M+64.8%

Other financials

Income statement

See full
Gross profit$32.4M+24.0%
Operating income-$41.5M+21.5%
Net income$6.0M+114%
EPS (diluted)$0.08+114%

Balance sheet

See full
Cash & equivalents$292.9M+26.3%
Total debt$108.0M-5.5%
Total equity$329.0M-4.1%
Total assets$640.4M-7.0%

Cash flow

See full
Operating cash flow-$34.1M
CapEx$362.0K+15.3%
Free cash flow-$34.4M

Valuation

See full
Market cap$1.33B-6.1%
Enterprise value$1.15B-11.8%
P/S5.1×-0.8×

Profitability

See full
Gross margin56.9%-1.6pp
Operating margin-59.2%-12.6pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.6×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: Schrodinger’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:08 PM EDT
Fiscal quarter
Q4 FY2026
Calendar quarter
Q4 2026
Accession
0001490978-26-000068
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Software products and services (includes related party revenue of $3, $11, $6, and $20)$32,544$36,031$68,104$81,003
Drug discovery22,98613,94045,86524,176
Contribution (includes related party revenue of $3,359, $4,725, $3,430, and $9,068)3,3594,7883,5079,131
Total revenues58,88954,759117,476114,310
Cost of revenues:
Software products and services9,4498,78720,31217,899
Drug discovery15,79415,14032,10429,592
Contribution1,2144,6743,0819,537

Item 1. Financial Statements.

FAQ

What is Schrodinger's total revenue?
Schrodinger (SDGR) reported total revenue of $58.89M in Q2 2026.
How has Schrodinger's total revenue changed year-over-year?
Schrodinger's total revenue increased by 7.5% year-over-year, from $54.76M to $58.89M.
What is the long-term trend for Schrodinger's total revenue?
Over 4 years (2021 to 2025), Schrodinger's total revenue has grown at a 16.7% compound annual growth rate (CAGR), from $137.93M to $255.87M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Schrodinger's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude